Measures of Mortality in Coronavirus (COVID-19) Compared With SARS and MERS
Journal of Cellular & Molecular Anesthesia,
Vol. 5 No. 2 (2020),
21 July 2020
In late 2019, a novel coronavirus, now designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of an outbreak of acute respiratory illness in Wuhan, a city in China. Mortality rate, case fatality rate, and Years of Potential Life Lost can be measured by determining death cases. Much of our information on mortality rates of diseases can be obtained through a regular implementation of care plans that are often developed to screen infectious diseases. In the YLL component, the higher the individuals die at an earlier age, the longer their life is lost. For COVID-19, this component refers to the simple subtraction of age at death due to COVID-19 from the standardized life expectancy for the same age in the same sex. A potential application of health summary indices is to consider the non-fatal consequences of diseases to ensure that they are taken into account in health policy making. Given that COVID-19 has a non-fatal effect on a large number of patients, the estimation of disease burden using the DALYs may be an appropriate index for achieving this goal.
- Mortality rate
- Case fatality rate
How to Cite
Ghelichi-Ghojogh M, Allah Kalteh E, Fararooei M. Coronavirus disease 2019; epidemiology and recommendations. J Prev Epidemiol. 2020;5(1):e01.
Mubarak M, Nasiri H. COVID-19 nephropathy; an emerging condition caused by novel coronavirus infection. J Nephropathol. 2020;9(3):e21.
Tolouian R, Zununi Vahed S, Ghiyasvand S, Tolouian A, Ardalan MR. COVID-19 interactions with angiotensin-converting enzyme 2 (ACE2) and the kinin system; looking at a potential treatment. J Renal Inj Prev. 2020; 9(2): e19.
Valizadeh R, Baradaran A, Mirzazadeh A, Bhaskar LVKS. Coronavirus-nephropathy; renal involvement in COVID-19. J Renal Inj Prev. 2020; 9(2):e18.
Hamidian Jahromi A, Mazloom S, Ballard DH. What the European and American health care systems can learn from China COVID-19 epidemic; action planning using purpose designed medical telecommunication, courier services, homebased quarantine, and COVID-19 walk-in centers. Immunopathol Persa. 2020;6(2):e17.
World, Health, Organisation. Coronavirus disease (COVID-2019) situation report 112 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
Mahase E. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ. 2020;368:m641.
Aryaie M, Roshandel G, Semnani S, Asadi-Lari M, Aarabi M, Vakili MA, et al. Predictors of Colorectal Cancer Survival in Golestan, Iran: A Population-based Study. Epidemiology and health. 2013;35:e2013004.
Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020;14(2):125-8.
Thacker SB, Choi K, Brachman PS. The surveillance of infectious diseases. JAMA. 1983;249(9):1181-5.
Canoy D. A dictionary of epidemiology — The evolution towards the 6th edition. BBA Clin. 2015;4:42-3.
Lahariya CD. An evolving common language in epidemiology. Indian J Community Med. 2015;40(4):286.
Porta M. A dictionary of epidemiology, 5th edition. A call for submissions through an innovative wiki. J Epidemiol Community Health. 2006;60(8):653.
Jung SM, Akhmetzhanov AR, Hayashi K, Linton NM, Yang Y, Yuan B, et al. Real-Time Estimation of the Risk of Death from Novel Coronavirus (COVID-19) Infection: Inference Using Exported Cases. J Clin Med. 2020;9(2).
Aleebrahim-Dehkordi E, Reyhanian A, Saberianpour S, Hasanpour-Dehkordi A. Acute kidney injury in COVID-19; a review on current knowledge. J Nephropathol. 2020;9(4):e31-e.
Valizadeh R, Dadashzadeh N, Zakeri R, James Kellner S, Rahimi MM. Drug therapy in hospitalized patients with very severe symptoms following COVID-19. J Nephropharmacol. 2020;9(2):e21-e.
Dadashzadeh N, Farshid S, Valizadeh R, Nanbakhsh M, Rahimi MM. Acute respiratory distress syndrome in COVId-19 disease. Immunopathol Persa. 2020; 6(2):e16. 1
Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Lancet Glob Health. 2020.
Wan K, Chen J, Lu C, Dong L, Wu Z, Zhang L. When will the battle against novel coronavirus end in Wuhan: A SEIR modeling analysis. J Glob Health. 2020;10(1):011002.
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020.
Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health. 2020;8(4):e480.
Heymann DL, Shindo N. COVID-19: what is next for public health? Lancet. 2020;395(10224):542-5.
Lazzerini M, Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. Lancet Glob Health. 2020;8(5):e641-e2.
Keramarou M, Evans MR. Completeness of infectious disease notification in the United Kingdom: A systematic review. J Infect. 2012;64(6):555-64.
Brewster L, Tarrant C, Dixon-Woods M. Qualitative study of views and experiences of performance management for healthcare-associated infections. The Journal of hospital infection. 2016;94(1):41-7.
Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011-9.
Gao H, Yao H, Yang S, Li L. From SARS to MERS: evidence and speculation. Front Med. 2016;10(4):377-82.
Lai A, Bergna A, Acciarri C, Galli M, Zehender G. Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2. J Med Virol. 2020;92(6):675-9.
Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med. 2020;27(2).
Majumder MS, Rivers C, Lofgren E, Fisman D. Estimation of MERS-Coronavirus Reproductive Number and Case Fatality Rate for the Spring 2014 Saudi Arabia Outbreak: Insights from Publicly Available Data. PLoS Curr. 2014;6.
Smith BA. A novel IDEA: The impact of serial interval on a modified-Incidence Decay and Exponential Adjustment (m-IDEA) model for projections of daily COVID-19 cases. Infect Dis Model. 2020;5:346-56.
Peeri NC, Shrestha N, Rahman MS, Zaki R, Tan Z, Bibi S, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? Int J Epidemiol. 2020.
Zhang S, Diao M, Yu W, Pei L, Lin Z, Chen D. Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis. Int J Infect Dis. 2020;93:201-4.
Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395-400.
Nussbaumer-Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, et al. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst Rev. 2020;4(4):Cd013574.
Yin S, Njai R, Barker L, Siegel PZ, Liao Y. Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model. Popul Health Metr. 2016;14:22.
Naghavi M, Abolhassani F, Pourmalek F, Lakeh M, Jafari N, Vaseghi S, et al. The burden of disease and injury in Iran 2003. Popul Health Metr. 2009;7:9.
- Abstract Viewed: 258 times
- PDF Downloaded: 175 times